Bahram Valamehr
2021
In 2021, Bahram Valamehr earned a total compensation of $6.5M as Chief Research and Development Officer at Fate Therapeutics, a 163% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $172,000 |
|---|---|
| Option Awards | $500,000 |
| Salary | $430,000 |
| Stock Awards | $5,375,416 |
| Total | $6,477,416 |
Valamehr received $5.4M in stock awards, accounting for 83% of the total pay in 2021.
Valamehr also received $172K in non-equity incentive plan, $500K in option awards and $430K in salary.
Rankings
In 2021, Bahram Valamehr's compensation ranked 1,945th out of 12,415 executives tracked by ExecPay. In other words, Valamehr earned more than 84.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,945 out of 12,415 | 84th |
Division Manufacturing | 735 out of 5,505 | 87th |
Major group Chemicals And Allied Products | 283 out of 2,375 | 88th |
Industry group Drugs | 242 out of 2,096 | 89th |
Industry Biological Products, Except Diagnostic Substances | 71 out of 449 | 84th |
Source: SEC filing on April 25, 2022.
Valamehr's colleagues
We found five more compensation records of executives who worked with Bahram Valamehr at Fate Therapeutics in 2021.